ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,235.72
-0.33%
Dow Jones
38,571.03
0.00%
Gold vs US Dollar
2,327.975
-0.98%
Brent Oil
77.135
-1.29%
Bitcoin
69,035.27
0.34%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ARYA Sciences Acquisition Corporation IV (ARYD)

  7. ARYA Sciences Acquisition Corporation IV (ARYD) News

ARYA Sciences Acquisitio... (ARYD)

ARYA Sciences Acquisition Corporation IV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARYD
DateTimeSourceHeadlineSymbolCompany
03/06/202411:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
03/06/202411:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
21/05/202402:31Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
20/05/202422:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
16/05/202421:41Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
16/05/202421:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
06/05/202411:25GlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
28/02/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
28/02/202422:02Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
26/02/202421:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
26/02/202421:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
15/02/202421:34Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
15/02/202421:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202421:16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202421:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202413:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202411:29PR Newswire (US)Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
14/02/202411:06PR Newswire (US)Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
09/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/02/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
01/02/202422:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
30/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
22/01/202422:20Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/01/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
04/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
09/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/11/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
02/10/202322:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
27/09/202321:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
05/09/202311:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARYDARYA Sciences Acquisition Corporation IV
 Showing the most relevant articles for your search:NASDAQ:ARYD

Your Recent History

LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
AAZ
Anglo Asian Mining
LSE
PFC
Petrofac
LSE
BP.
Bp
LSE
SOLG
Solgold
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
LSE
TERN
Tern
LSE
ITM
Itm Power
LSE
GKP
Gulf Keystone Petroleum
LSE
DEMG
Deltex Medical
LSE
ENET
Ethernity Networks
LSE
BIRD
Blackbird
LSE
EBOX
Tritax Eurobox
LSE
RKH
Rockhopper Exploration
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved